rxstat › Shortages › Rupatadine
Rupatadine (Rupall) shortage status
No current shortage
An antihistamine used to relieve allergy symptoms such as hay fever and hives.
Shortage history
Reports by product
What's happening
There are no active shortage reports for Rupatadine. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Rupatadine is classified under “ANTIHISTAMINES FOR SYSTEMIC USE” (ATC R06AX).
Recent changes
- Nov 9, 2026 Shortage resolved
- Nov 5, 2026 Shortage resolved
- Oct 30, 2026 Estimated end date pushed back : Oct 30, 2026 → Nov 9, 2026
- Oct 30, 2026 New report filed
- Oct 16, 2026 Estimated end date pushed back : Oct 19, 2026 → Oct 30, 2026
- Oct 5, 2026 Status changed
- Oct 5, 2026 Estimated end date pushed back : Oct 5, 2026 → Oct 19, 2026
- Sep 14, 2026 New report filed
Common questions
What is Rupatadine used for?
An antihistamine used to relieve allergy symptoms such as hay fever and hives.
When will Rupatadine be back in stock in Canada?
Rupatadine has no active shortage; supply is normal per Health Canada reports.
Why is Rupatadine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (antihistamines for systemic use)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.